Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1568406445
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3400 Spruce Street, 15 Penn Tower
Philadelphia, PA, 19104
Phone (215) 662-3914
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
800 services
Medicare patients, 2024
161
Average age 74
Drug cost, 2024
$4.8M
782 prescriptions
Company payments, 2025
$1,982
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eric J Sherman was code 99215 (office e&m - established), 365 times for 111 patients. In total Eric J Sherman billed 800 services in 8 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 365 | 111 | $125.02 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 290 | 124 | $14.32 | $4,152 |
| 99214 Office E&M - Established | Office | 78 | 60 | $88.62 | $6,912 |
| 99205 Office E&M - New | Office | 24 | 24 | $162.06 | $3,890 |
By year: 2022 $80K for 686 services; 2023 $62K for 542 services; 2024 $64K for 800 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eric J Sherman prescribed most often to Medicare patients was Levothyroxine Sodium, with 153 prescriptions and refills. In total Eric J Sherman wrote 782 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 153 | 277 | 35 | $1,747 |
| Tafinlar Dabrafenib Mesylate | 142 | 144 | 25 | $2.0M |
| Mekinist Trametinib Dimethyl Sulfoxide | 63 | 63 | 17 | $1.1M |
| Synthroid Levothyroxine Sodium | 59 | 94 | 12 | $3,985 |
| Lenvima Lenvatinib Mesylate | 45 | 45 | Under 11 | $938K |
| Prednisone Generic | 39 | 43 | 12 | $146 |
| Retevmo Selpercatinib | 32 | 32 | Under 11 | $504K |
| Amlodipine Besylate Generic | 27 | 39 | Under 11 | $120 |
| Oxycodone Hcl Generic | 15 | 15 | Under 11 | $221 |
| Dexamethasone Generic | 13 | 13 | Under 11 | $192 |
| Ondansetron Odt Ondansetron | 12 | 12 | Under 11 | $241 |
| Pazopanib Hcl Generic | 12 | 12 | Under 11 | $99K |
| Metoprolol Succinate Generic | 12 | 22 | Under 11 | $289 |
Brand drugs: 400 claims; generic drugs: 382 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eric J Sherman $1,982 ($1,982 in general payments such as food, travel and fees) from 4 companies. The largest payer was Eisai Inc. with $1,963.
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. 4523.T | 1 | $1,963 |
| Grifols USA, LLC | 1 | $19.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.